Esonix 40 mg/vial (IV Injection)
40 mg vial: ৳ 110.00
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Relief from chronic heartburn symptoms and other symptoms associated with GERD
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection in patients with duodenal ulcer disease in combination with amoxicillin and clarithromycin
- Zollinger-Ellison Syndrome
- Acid-related Dyspepsia
- Duodenal & Gastric ulcer
Pharmacology
- Proton pump inhibitor
- Inhibits gastric acid secretion
- Formulated with enteric-coated pellets
- Peak plasma levels occur at approximately 1.5 hours after oral administration
- Metabolized in the liver by cytochrome P450 enzyme system
Dosage
- Healing of erosive esophagitis: 20 mg or 40 mg once daily for 4-8 weeks
- Symptomatic GERD: 20 mg once daily for 4 weeks
- Maintenance of Healing of Erosive Esophagitis: 20 mg once daily
- Helicobacter Pylori eradication: Triple Therapy for 10 days
- Zollinger-Ellison Syndrome: 20-80 mg once daily
- Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks
- Duodenal ulcer: 20 mg once daily for 2-4 weeks, Gastric ulcer: 20-40 mg once daily for 4-8 weeks
- IV Injection or IV infusion for various conditions based on patient age and weight
Administration
- Tablet or capsule should be swallowed whole and taken one hour before a meal
- Proper administration of oral suspension
- Preparation of IV Injection solution
- Use of antacids while taking the product
Interaction
- Metabolized in the liver by CYP2C19 and CYP3A4
- Unlikely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1, and 3A4
- Potential interference with the absorption of drugs where gastric pH is important
- Effects of combination therapy with clarithromycin
Contraindications
- Contraindicated in patients with known hypersensitivity to any of the formulation
Side Effects
- Headache
- Diarrhoea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- No teratogenic effects in animal studies
- Excretion in milk not studied, breastfeeding should be discontinued if essential
Precautions & Warnings
- Symptomatic response to therapy does not preclude the presence of gastric malignancy
- Guidelines for patients with difficulty swallowing capsules
Use in Special Populations
- Safety and effectiveness not established in paediatric patients
- No overall differences in safety and efficacy in the elderly
- No dosage adjustment recommended for patients with mild to moderate hepatic insufficiency
- Pharmacokinetics not expected to be altered in patients with renal impairment
Overdose Effects
- Lethal dose in rats
- Signs of acute toxicity include reduced motor activity, changes in respiratory frequency, tremor, ataxia, and convulsions
- No specific antidote known, treatment should be symptomatic and supportive
Storage Conditions
- Store at a temperature not exceeding 30°C in a dry place
- Protect from light and moisture
- Keep out of reach of children
Chemical Structure
- Molecular Formula: C17H19N3O3S
- Chemical Structure Image: Available
Commonly Asked Questions
- Information about Esonix 40 mg/vial Injection
- Uses, side effects, pregnancy/breastfeeding, time to work, and quick tips
Compound Summary
Please refer to the 'Chemical Structure' attribute for details.
Related Brands
- S-Ome 20 mg (Tablet (Enteric Coated)) - somatec-pharmaceuticals-ltd
- S-Ome 40 mg (Tablet (Enteric Coated)) - somatec-pharmaceuticals-ltd
- Alton 20 mg (Tablet (Enteric Coated)) - general-pharmaceuticals-ltd
- Alton 40 mg (Tablet (Enteric Coated)) - general-pharmaceuticals-ltd
- Asector 20 mg (Capsule (Enteric Coated)) - novo-healthcare-and-pharma-ltd